Dogs impacted by chronic kidney disease (CKD) can live more manageable lives thanks to a new study from experts at the Koret ...
A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...
There’s no cure for hypoparathyroidism, but treatment options like calcium supplements, diuretics, and parathyroid hormone therapy can help regulate your calcium and phosphate levels.
A phase 3 trial of AstraZeneca’s $800 million rare disease candidate has met its primary endpoint. The update keeps ...
High ionized calcium levels were associated with an increased risk for hyperparathyroidism, especially among men.
The study, published in the Journal of Veterinary Internal Medicine, examined the effects of paricalcitol -- a synthetic form ...
High-level results from the CALYPSO Phase III trial showed that eneboparatide, AZP-3601, an investigational parathyroid hormone receptor 1 ...
AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and ...
A new study led by Dr. Hilla Chen, Prof. Gilad Segev and Dr. Michal Mazaki-Tovi from the Koret School of Veterinary Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results